1. Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
   Locke D. Uppendahl et al, 2018, Front. Immunol. CrossRef
2. Membrane bound IL-21 based NK cell feeder cells drive robust expansion and metabolic activation of NK cells
   Evelyn O. Ojo et al, 2019, Sci Rep CrossRef
3. Effect of autologous NK cell immunotherapy on advanced lung adenocarcinoma with EGFR mutations
   Guodai Hong et al, 2019 CrossRef
4. Harnessing natural killer cells for the treatment of ovarian cancer
   Janneke S. Hoogstad-van Evert et al, 2020, Gynecologic Oncology CrossRef
5. Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
   Yuqing Cao et al, 2020, Sig Transduct Target Ther CrossRef
6. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I−/− iPSCs for β cell replacement
   Raniero Chimienti et al, 2022, Cell Reports CrossRef
7. Ovarian cancer treatment and natural killer cell-based immunotherapy
   Zhongru Fan et al, 2023, Front. Immunol. CrossRef
8. Adoptive T cell therapy for ovarian cancer
   Sarah B. Gitto et al, 2024, Gynecologic Oncology CrossRef